| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00014 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.00019 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.00012 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -1.2e-05 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 1.1e-05 | 1 |